Works matching DE "PROTEIN kinase inhibitors"
Results: 2820
Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 568, doi. 10.3390/cancers17040568
- By:
- Publication type:
- Article
Knockin' on Cell's Door: Influenza A Virus Adsorption and Its Pharmacological Inhibition.
- Published in:
- Microbiology Research, 2025, v. 16, n. 2, p. 37, doi. 10.3390/microbiolres16020037
- By:
- Publication type:
- Article
OsEL2 Regulates Rice Cold Tolerance by MAPK Signaling Pathway and Ethylene Signaling Pathway.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1633, doi. 10.3390/ijms26041633
- By:
- Publication type:
- Article
Targeted therapy for metastatic colorectal cancer: what do we currently have in clinical practice?
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 5, p. 222, doi. 10.1007/s40267-022-00915-9
- By:
- Publication type:
- Article
Trilaciclib for the reduction of chemotherapy-induced myelosuppression in the management of extensive-stage small cell lung cancer: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 2, p. 64, doi. 10.1007/s40267-021-00889-0
- By:
- Publication type:
- Article
Personalized Care in the Prevention of Treatment-Related Cardiac Dysfunction in Female Cancer Survivors.
- Published in:
- Journal of Women's Health (15409996), 2019, v. 28, n. 10, p. 1384, doi. 10.1089/jwh.2018.6979
- By:
- Publication type:
- Article
Redox‐Neutral Vicinal Difunctionalization of Five‐Membered Heteroarenes with Dual Electrophiles.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 50, p. 26388, doi. 10.1002/ange.202110971
- By:
- Publication type:
- Article
Efficacy and safety of endoxifen in bipolar disorder: A systematic review.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2024, v. 39, n. 4, p. 1, doi. 10.1002/hup.2899
- By:
- Publication type:
- Article
Vicagrel is hydrolyzed by Raf kinase inhibitor protein in human intestine.
- Published in:
- Biopharmaceutics & Drug Disposition, 2022, v. 43, n. 6, p. 247, doi. 10.1002/bdd.2340
- By:
- Publication type:
- Article
Ouabain Accelerates Collective Cell Migration Through a cSrc and ERK1/2 Sensitive Metalloproteinase Activity.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model.
- Published in:
- Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-019-1070-4
- By:
- Publication type:
- Article
Is Clinical Risk Score a Useful Predictive Marker of Early Recurrence Among Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors?
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 2, p. 106, doi. 10.14744/ejmi.2024.52208
- By:
- Publication type:
- Article
Overcoming Hormone Resistance in Breast Cancer Cell Lines: The Impact of Combined Treatment with Sorafenib and Palbociclib on Cell Survival and Proliferation Pathways.
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 1, p. 13, doi. 10.14744/ejmi.2023.14963
- By:
- Publication type:
- Article
The Expression Profiles of Angio-miRs in Glioblastomas Invasion Inhibited by Ruxolitinib.
- Published in:
- Namık Kemal Tıp Dergisi, 2022, v. 10, n. 1, p. 15, doi. 10.4274/nkmj.galenos.2021.25238
- By:
- Publication type:
- Article
Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy.
- Published in:
- European Journal of Therapeutics, 2024, v. 30, n. 5, p. 662, doi. 10.58600/eurjther2151
- By:
- Publication type:
- Article
Ribociclib-induced cutaneous adverse events in metastatic HR+/HER2- breast cancer: Incidence, multidisciplinary management, and prognostic implication.
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 5
- By:
- Publication type:
- Article
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1).
- Published in:
- Breast Cancer Research Review, 2023, n. 40, p. 5
- By:
- Publication type:
- Article
Overall survival with ribociclib plus letrozole in advanced breast cancer.
- Published in:
- Breast Cancer Research Review, 2022, n. 37, p. 4
- By:
- Publication type:
- Article
Subsequent-abemaciclib treatment after disease progression on palbociclib in patients with ER-positive HER2-negative metastatic breast cancer.
- Published in:
- Breast Cancer Research Review, 2022, n. 36, p. 5
- By:
- Publication type:
- Article
Inhibitor of Multi-cyclin-dependent Kinases (AT7519) Reduced Survival of U937 Leukemic Cells and Enhanced Anti-leukemic Effect of Vincristine: A Highlight to CDK Inhibition Efficacy in Acute Leukemia.
- Published in:
- International Journal of Cancer Management, 2021, v. 14, n. 2, p. 1, doi. 10.5812/ijcm.101366
- By:
- Publication type:
- Article
Current evidence on thyroid related adverse events in patients treated with protein tyrosine kinase inhibitors.
- Published in:
- Drug Metabolism Reviews, 2019, v. 51, n. 4, p. 562, doi. 10.1080/03602532.2019.1687512
- By:
- Publication type:
- Article
7,8-Dihydroxyflavone protects neurons against oxygen-glucose deprivation induced apoptosis and activates the TrkB/Akt pathway.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.12886
- By:
- Publication type:
- Article
Principiile cercetării imunofarmacologice.
- Published in:
- Farmacist.ro, 2020, n. 4, p. 25
- By:
- Publication type:
- Article
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Insulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocytes2.
- Published in:
- Journal of Animal Science, 2008, v. 86, p. E94, doi. 10.2527/jas.2007-0462
- Publication type:
- Article
Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2022.2153841
- By:
- Publication type:
- Article
Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, v. 29, n. 3, p. 338, doi. 10.3109/14756366.2013.782024
- By:
- Publication type:
- Article
Factors influencing the inhibition of protein kinases.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2012, v. 27, n. 2, p. 194, doi. 10.3109/14756366.2011.583922
- By:
- Publication type:
- Article
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer.
- Published in:
- British Journal of Healthcare Management, 2016, v. 22, n. 10, p. 486, doi. 10.12968/bjhc.2016.22.10.486
- By:
- Publication type:
- Article
Nintedanib for treating idiopathic pulmonary fibrosis.
- Published in:
- British Journal of Healthcare Management, 2016, v. 22, n. 5, p. 250, doi. 10.12968/bjhc.2016.22.5.250
- By:
- Publication type:
- Article
Potentially Practice-Changing: Ribociclib/Letrozole Combo in Advanced Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 9, p. 381
- Publication type:
- Article
"Magic Mouthwash" and the Management of mTOR Inhibitor-Associated Stomatitis.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 7, p. 304
- By:
- Publication type:
- Article
RAF Family Inhibitor Has Preliminary Activity in Multiple Types of Tumors.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 6, p. 242
- Publication type:
- Article
Midostaurin: First Targeted Therapy in AML Is Potentially Practice Changing.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 37
- Publication type:
- Article
BRAF Mutation in Colorectal Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 14
- By:
- Publication type:
- Article
The Current Landscape in Melanoma Treatment.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 6, p. 310
- Publication type:
- Article
CDK 4/6 Inhibitor Slows Progression of Metastatic Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 4, p. 230
- Publication type:
- Article
Molecular Monitoring Can Provide Treatment Guidance in CML.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 175
- Publication type:
- Article
New Melanoma Guideline Adds BRAF Inhibitor, MEK Inhibitor to First-Line Systemic Therapy Options.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 170
- By:
- Publication type:
- Article
Molecular Therapy Beyond Sorafenib in HCC: New Pathways, Targets Being Explored.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 2, p. 119
- Publication type:
- Article
Angiotensin System Inhibitors Extend Survival in Patients With Metastatic Renal Cell Carcinoma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 2, p. 114
- Publication type:
- Article
Clopidogrel Protects Endothelium by Hindering TNFα-Induced VCAM-1 Expression through CaMKKβ/AMPK/Nrf2 Pathway.
- Published in:
- Journal of Diabetes Research, 2015, p. 1, doi. 10.1155/2016/9128050
- By:
- Publication type:
- Article
Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart.
- Published in:
- Journal of Physiology, 2017, v. 595, n. 12, p. 4073, doi. 10.1113/JP274064
- By:
- Publication type:
- Article
RON Mediates Tumor-Promoting Effects in Endometrial Adenocarcinoma.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/2282916
- By:
- Publication type:
- Article
Effects of Ulinastatin on Proliferation and Apoptosis of Breast Cancer Cells by Inhibiting the ERK Signaling Pathway.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9999268
- By:
- Publication type:
- Article
Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6613439
- By:
- Publication type:
- Article
PICK1 Deficiency Exacerbates Sepsis-Associated Acute Kidney Injury.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9884297
- By:
- Publication type:
- Article
BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5556306
- By:
- Publication type:
- Article
Identification of Key miRNAs in the Treatment of Dabrafenib-Resistant Melanoma.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5524486
- By:
- Publication type:
- Article
Cediranib Induces Apoptosis, G1 Phase Cell Cycle Arrest, and Autophagy in Non-Small-Cell Lung Cancer Cell A549 In Vitro.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5582648
- By:
- Publication type:
- Article